Xmet-Trio 500/0.2/2 Tablet ER
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Xmet-Trio 500/0.2/2 Tablet ER
Tricita 500/0.2/2 Extended-Release Tablets are classified as antidiabetic medications. This combined formulation treats type 2 diabetes in adults by managing blood glucose levels. Tricita 500/0.2/2 ER should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Familiarize yourself with its symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Consistent mealtimes and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are crucial for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals must consult their physician before use. Regular blood glucose monitoring and periodic blood tests (complete blood count, liver function tests) may be recommended by your doctor.
Primary Ingredients of Xmet-Trio 500/0.2/2 Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Xmet-Trio 500/0.2/2 Tablet ER
Managing Type 2 Diabetes
Major Benefits of Xmet-Trio 500/0.2/2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Xmet-Trio 500/0.2/2 Extended-Release Tablet should be taken on an empty stomach.
Common Side effects of Xmet-Trio 500/0.2/2 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Xmet-Trio 500/0.2/2 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Xmet-Trio 500/0.2/2 Tablet ER on an empty stomach.
How Xmet-Trio 500/0.2/2 Tablet ER works:
Extended-release Xmet-Trio tablets (500mg/0.2mg/2mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Xmet-Trio 500/0.2/2 Tablet ER with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Xmet-Trio 500/0.2/2 tablet might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Xmet-Trio 500/0.2/2 tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyUNSAFE
Employing Xmet-Trio 500/0.2/2 Tablet ER in individuals with kidney impairment poses a likely risk and should be prevented. Medical advice is necessary. Furthermore, its use is discouraged for those with severe kidney dysfunction.
LiverCAUTION
Exercise caution when prescribing Xmet-Trio 500/0.2/2 Tablet ER to individuals with hepatic impairment. Dosage modification of Xmet-Trio 500/0.2/2 Tablet ER might be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, Xmet-Trio 500/0.2/2 Tablet ER should typically commence at a reduced dosage; its administration is contraindicated in cases of severe liver disease.
What if you forget to take Xmet-Trio 500/0.2/2 Tablet ER :
Should you forget a dose of Xmet-Trio 500/0.2/2 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Xmet-Trio 500/0.2/2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently